GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
2 246,00 INR
arrow_downward
-0,85%(-19,30) 1D
14-окт., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
2 275,00 INR
High
2 286,40 INR
Low
2 242,00 INR
Mkt. cap
633,49 млд
Avg. vol.
576,02 миң
Volume
257,94 миң
Dividend
0,22%
Quarterly dividend
1,25 INR
Ex-dividend date
2025-ж., 3-окт.
P/E ratio
35,27
52-wk high
2 537,60 INR
52-wk low
1 792,60 INR
EPS
63,68 INR
Shares outstanding
0,00
No. of employees
17 миң
Open
2 275,00 INR
High
2 286,40 INR
Low
2 242,00 INR
Mkt. cap
633,49 млд
Avg. vol.
576,02 миң
Volume
257,94 миң
Dividend
0,22%
Quarterly dividend
1,25 INR
Ex-dividend date
2025-ж., 3-окт.
P/E ratio
35,27
52-wk high
2 537,60 INR
52-wk low
1 792,60 INR
EPS
63,68 INR
Shares outstanding
0,00
No. of employees
17 миң
News stories
From web sources and news partners
GuruFocus
·
6 мүнөт мурун
HSBC Sees a Surprise Driver for the Next Stock Rally
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd